Eiger Biopharmaceuticals has raised $7.1 million in a first round of venture funding, according to Private Equity Hub. The Palo Alto, Calif. startup doesn’t have a website, and we don’t have any details about the company at this time. Investors include InterWest Partners and Vivo Ventures.

VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative enterprise technology and transact. Learn more about membership.